Does DURVALUMAB Cause Neutrophil count decreased? 343 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 343 reports of Neutrophil count decreased have been filed in association with DURVALUMAB (IMFINZI). This represents 2.0% of all adverse event reports for DURVALUMAB.
343
Reports of Neutrophil count decreased with DURVALUMAB
2.0%
of all DURVALUMAB reports
49
Deaths
76
Hospitalizations
How Dangerous Is Neutrophil count decreased From DURVALUMAB?
Of the 343 reports, 49 (14.3%) resulted in death, 76 (22.2%) required hospitalization, and 185 (53.9%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
Yes, Neutrophil count decreased is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which DURVALUMAB Alternatives Have Lower Neutrophil count decreased Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE